Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> I'm always amazed how startups like this where R&D practically cost nothing are not profitable yet

S&M is a helluva drug. Notice something common about the "Other SG&A" in all of these?

https://www.marketwatch.com/investing/stock/mdb/financials

https://www.marketwatch.com/investing/stock/cldr/financials

https://www.marketwatch.com/investing/stock/rht/financials

At the end of the day, DCF is really what matters and DCF != profit



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: